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SUMMARY 
Several amino acids have been synthesized as model transport substrates 
building on the piperidine and cyclohexane rings. Only when the distal N atom is 
part of an unambiguously cationic structure are these compounds transported 
predominantly by the cationic amino acid system. These amino acids in labeled form 
are excreted rather slowly in unmodified state, very little 14CO2 being released. Those 
which are unambiguously cationic (including also homoarginine) led to a greatly 
increased excretion of arginine, lysine, ornithine and citrulline. Those which might be 
expected to act as lysine analogs had little effect on the excretion of the basic amino 
acids, although the excretion of citrulline and the sum of glutamine plus asparagine 
was accelerated. Certain of the analogs intensified the excretion of citrulline in 
dissociation from effects on resorption of the basic amino acids, also in dissociation 
from effects on cystine resorption. These results indicate citrulline resorption does 
not occur principally by the same agency serving for the basic amino acids, nor by the 
agency serving for cystine, despite the observed interactions for resorption. The 
injection of either of three transport analogs for arginine into the rat leads to early 
increases in the circulating levels of immunologicaUy reactive insulin and glucagon. 
INTRODUCTION 
To study some rather mystifying interactions between basic and neutral amino 
acids (including particularly cystine) for renal tubular transport, and to study other 
aspects of the transport of cationic amino acids, we have synthesized a series of  
non-metabolizable amino acid analogs built on the piperidine ring system. The 
following features seemed to us desirable for inclusion in a model substrate for study 
of  a general transport system for basic amino acids: (1) An unambiguously cationic 
Abbreviations: PA, 4-aminopiperidine-4-carboxylic acid; CPA, 4-amino-l-carbamoyl- 
piperidine-4-carboxylic acid; GPA, 4-amino-l-guanylpiperidine-4-carboxylic acid; PG, 4- 
piperidineglycine; MPA and M~PA, 4-amino-l-methyl- and 4-amino-l,l-dimethylpiperidine-4- 
carboxylic acid, respectively. 
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group removed by three or more carbon atoms from ~t-amino group. (2) Several 
methylene groups to produce high affinity. The optimal distribution of  these groups 
in space is not well known. (3) To minimize metabolic attack, a cyclic structure, 
thereby avoiding any chain-ending methyl or methylene group, and at the same time 
avoiding the presence of  a hydrogen atom on the g-carbon. We expected to find, 
however, a disadvantage to reactivity from the presence of  two fl-carbon atoms, 
because 1-aminocyclopentanecarboxylic acid has proved a weak inhibitor of the 
uptake of basic amino acids in the presence of  Na + (ref. 4). That is, two fl-carbon 
atoms do not appear to be accommodated freely at this transport site in the cells we 
have studied, even if these two carbon atoms are part of a ring structure. (4) A cyclic 
structure to fix the position of the terminal cationic group in space with reference to 
the ~t-amino and carboxyl groups. Here again, the absence of detectable inhibition 
of  lysine uptake by proline in the presence of Na ÷ (ref. 4) generated doubt that the 
otherwise promising aminoprolines or aminopipecolic acids could be accommodated 
at the site to provide evidence (such as that obtained for the topography of Site 
A S C  6) for the position in space of the structure recognizing the terminal basic group 
at Site L.~*. 
Heretofore we have used homoarginine as a model substrate for System L J). 
Although it includes only the first two features listed above, it is metabolically more 
stable than arginine. In the present work, an amino and a carboxyl group were 
introduced on C-4 of piperidine to generate a lysine analog. 4-Piperidineglycine was 
prepared as another lysine analog 7. 
In studies of  the transport of  these compounds into the Ehrlich cell reported 
elsewhere s we find that the nitrogen atom of the piperidine ring, or the amino group 
of an amino acid built on the cyclohexane ring, fails to fulfill the role of the desired 
distal cationic group. On the contrary, several amino acids containing these struc- 
tures served as substrates of System L* as if their sidechains were uncharged. This 
behavior was especially conspicuous when the piperidine N was monomethylated, or 
when the 4-amino group of  1,4-diaminocyclohexane carboxylic acid had the cis 
orientation to the ~-amino group. 
This behavior suggests that the protonation of the piperidine N or other 
terminal amino group is sufficiently repressed at the receptor site for transport so 
that those compounds behave to a major extent as neutral amino acids. This repression 
might arise from an apolar environment at the appropriate region of  the receptor site. 
It seemed to us more likely, however, that the behavior reveals a decreased availability 
of the H + near the external surface of  the membrane, because exodus of these amino 
acids from the Ehrlich cell is extremely slow, as though the receptor site at the internal 
surface of the plasma membrane sees these amino acids, as expected, in an unsuitable 
state of protonation. Furthermore, the uptake of these amino acids generally is 
remarkably rapid and highly concentrative, permitting us to show unequivocally the 
strong uphill operation of  transport System L, and its sensitivity to inhibition both 
by 2,4-dinitrophenol and by oligomycin. The implications of these results are dis- 
cussed elsewhere s. 
Even lysine itself acts to some extent as a neutral amino acid in transport so 
that it cannot be trusted as a model substrate for cationic amino acid transport 
* The several transport systems mentioned are defined and summarized in ref. 5. 
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systems. The tendency to act as a neutral amino acid in transport is greatly enhanced 
in 0qT-diaminobutyric acid 9 and thialysine a, both showing a value of 8.4 for their 
second pK',, as against the value of 9.5 seen for lysine. For the first of these two 
amino acids it is System A rather than System L that accounts for a very high maximal 
velocity for uptake. For  the second, both systems show high maximal velocities 8. 
Hence these effects of  a rather weakly basic distal amino group in producing unusually 
rapid uptake against strong concentration gradients are not limited to a single 
transport system. 
To obtain unambiguously cationic amino acids, we then introduced the guanyl 
group on the piperidine N, so that the compounds 4-amino-l-guanylpiperidine-4- 
carboxylic acid (GPA) and 1-guanylpiperidine glycine (GPG) in Fig. 1 were made 
available as arginine analogs. These substances were fairly reactive with the transport 
system for cationic amino acids in all tested occurrences, but not with the systems for 
neutral amino acids. 
Proceeding in the opposite direction, we converted one of the lysine analogs 
into an unambiguously neutral amino acid, namely 4-amino-1-carbamoylpiperidine-4- 
carboxylic acid (CPA) which is a citrulline analog. 
One of our purposes in preparing these compounds was to test their ability to 
mimic the action of arginine and lysine in stimulating the release of insulin and 
glucagon from the pancreas, in parallel to the action of  2-aminonorbornane-2- 
carboxylic acid in mimicking the action of leucine in stimulating the pancreatic 
release of insulin 1°' it but not that of glucagon ~2. The effects of leucine and its non- 
metabolizable analog differ from those of arginine and lysine in several important 
respects. Although the action of  arginine cannot be accounted for by the effect of the 
ornithine to which it is converted, the view that it is the basic amino acid p e r  se  that is 
effective would be greatly strengthened if a non-metabolizable analog could be 
ClTRULLINE ANALOG SUPPOSED ARGININE ANALOGS 
LYSINE ANALOGS 
HOMOARGININE 
COO" COO" ~ "  NH~ ~ NH + ~ NH~ 
%G_N ~ J "I-HIN / ÷HI~c_N I I 
/ I HtN CPA PA HIN 61~ 
C00" C00- / / 
~NH3+ ÷HIN / XNH3+ 
+Hi N ~N 'C - -N / /  
/ 
P~ HIN G PG 
Fig. 1. Structures and abbreviations of the amino acid analogs used. PA= 4-aminopiperidine-4- 
carboxylic acid (the "piperidine amino acid"); CPA= 4-amino- l-carbamoylpiperidine-4-carboxylic 
acid (the "carbamoylpiperidine amino acid"); GPA=4-amino-l-guanylpiperidine-4-carboxylic 
acid; PG=4-piperidineglyeine; GPG=l-guanylpiperidineglycine. 4-Amino-l-methyl- and 4- 
amino-l,l-dimethylpiperidine-4-earboxylic acid (MPA and MzPA) may be visualized by replacing 
one or both of the hydrogen atoms on the piperidine N of PA with one or two methyl groups. 
AMINO ACID TRANSPORT SUBSTRATES 935 
shown also to produce this effect. We find and are now reporting that the much more 
slowly metabolized homoarginine also stimulates an increase in the immunologically 
reactive insulin of the plasma in the rat without appreciably raising the plasma lysine 
level; but more significantly GPA and GPG also increase the circulating level of 
insulin, and at the same time, that of glucagon. Preliminary reports of both of these 
findings have appeared 1'2. Subsequently, similar results have been obtained on 
intravenous infusion into the dog, as reported also in a preliminary way 12. In the 
meantime, GPA has also been shown in the laboratory of HeUman to stimulate the 
release of insulin from the pancreatic islet in vitro, using tissue microdissected from 
obese, diabetic mice u. 
The present communication reports also on the metabolic stability of some 
of these amino acids on injection into the rat, and on their effects on the excretion 
into the urine of the ordinary amino acids associated with clinical cystinuria. 
EXPERIMENTAL SECTION 
Synthesis of  analogs. Precursor ketones for Strecker or Bucherer-Libe synthesis 
p-Toluenesulfonate salt of  N-dimethyl-4-piperidone. 40 mmoles of N-methyl-4- 
piperidone (Aldrich) in 70 ml dry benzene was treated with 7.44 g of redistilled 
p-toluenesulfonic acid methyl ester, added dropwise. On standing overnight the 
solution became semi-rigid with almost colorless crystals. After filtering off 25 mmoles 
of product, the supernatant was refluxed 25 min. On cooling 6 mmoles more of light 
yellow product were collected. 
Tosyl derivatives of  4-piperidone and 4-aminocyclohexanone. 4-Hydroxy- 
piperidine. HCI was converted to N-p-toluenesulfonyl-4-piperidone, (m.p. = 125-126 
°C) according to the procedure of Arndt and Kalischek la. Similarly 4-aminocyclo- 
hexanol, 100 mmoles, was dissolved in 35 ml 4 M NaOH and treated at 50 °C with 
23.8 g (125 mmoles) p-toluenesulfonyl chloride added in 8-10 portions, stirring until 
each portion dissolved before adding the next. Additional NaOH was introduced to 
keep the pH distinctly alkaline. 
(The product could be obtained in two isomeric forms, one crystallizing from 
aqueous solution and purified by crystallization from chloroform, m.p. 166-167 °C, 
presumably the trans form. The other form could be extracted from the aqueous 
mother liquor with chloroform. This extract was taken to a small volume and the 
material remaining in solution crystallized by adding benzene. It melted at 113-114 °C. 
For our purposes, however, separation of the isomers was avoided.) 
The product was extracted from the aqueous solution with chloroform, the 
chloroform solution taken to a small volume, and an excess of benzene added. The 
crystalline precipitate, 17.5 g, was oxidized in glacial acetic acid solution with chromic 
oxide la, to yield 4-p-toluenesulfamidocyclohexanone, yield 82% of theoretical, melting 
point of crystals from glacial acetic acid, 115 °C. 
Strecker synthesis. Typical procedures frequently used in this laboratory 
(1) To 10 mmoles of N-dimethyl-4-piperidone as the p-toluenesulfonate salt 
in a test tube were added a solution of 10 mmoles each of KCN and NH4CI in 3.3 ml 
water. The tube was sealed in a flame, and the ketone dissolved by shaking. The 
tube was then held at about 65 °C for 4 h. To the cooled contents of the tube was 
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added in a hood a large excess of concentrated HCI, and the resulting solution 
refluxed 5 h to hydrolyze the aminonitrile. The hydrolysate was taken to dryness, 
and the residue dissolved in water and poured onto a column of Amberlite IR-120 
resin in the protonated form, using a 4-fold excess or more of the resin. After washing 
the resin bed with about 500 ml water, the amino acid was displaced by frontal 
elution with 0.5 M aqueous NHa. Collection of eluate was begun when its pH rose 
sharply into the neutral range, and continued until only a weak color was obtained 
with alcoholic ninhydrin applied to test spots on paper. The eluate was then taken 
to dryness in vacuo, and the residue taken up in boiling ethanol. Successive crops of 
crystals were taken to a total yield of 40% of theoretical. The product on heating 
decomposed at 225-230 °C with an amine-like odor. It was somewhat hygroscopic 
and samples developed a yellow color in a few months on the shelf. 
(2) 10 mmoles of 1-p-toluenesulfonyl-4-piperidone was dissolved in 13.3 ml 
methanol, and then a solution of 10 mmoles each of KCN and NH4C1 together in 
6.7 ml of water was added rapidly with mixing, and a glass stopper fastened firmly 
to close the flask. The resulting clear solution was held for 5 h at 50 °C. A few dense 
crystals appeared during the heating, and then half filled the solution on holding 
48 h at 5 °C. The presumed aminonitrile, 2.33 g, m.p. 137-139 °C, was collected by 
filtration and washing with 2:1 aqueous methanol. The intermediate was hydrolyzed 
by refluxing in a large excess of constant-boiling HC1 for 8 h beyond the time needed 
to obtain a clear solution. The amino acid was then separated in its isoionic form on 
an IR-120 resin column as described above, combining only the eluate portions that 
gave a copper-colored spot with ninhydrin, discarding any later portions of eluate 
that gave a light blue ninhydrin reaction, probably because of incomplete hydrolysis. 
After evaporating the ammoniacal eluate to dryness in vacuo, the residue was dissolved 
in a minimal quantity of hot 1 : 1 aqueous ethanol, and crystallization produced by 
adding an equal volume of ethanol. Two subsequent crops were taken at smaller 
volumes of the same solvent mixture, to give a total yield 42% of that theoretically 
possible from the quantity of the piperidone taken. Similar results were obtained, 
yield 54% of 4-aminopiperidine-4-carboxylic acid (PA), from Strecker synthesis in 
water solution from 1-acetyl-4-piperidone, which subsequently became commercially 
available. The product on heating sintered at 285-295 °C and decomposed gradually 
at above 305 °C. 
(3) 10 mmoles each of N-benzylpiperidone, KCN and NH4C1 were dissolved 
in 3 ml water plus 5 ml methanol. This solution was held 6 h at 60 °C in a sealed 
tube. The reaction mixture was hydrolyzed with HCI as in the first example, and the 
amino acid separated with an IR-120 H resin column, using for elution aqueous NH3 
at only 0.1 M to compensate for rather low solubility of the product. After evapo- 
rating the ammoniacal solution, the residue was recrystallized from water in 25% 
yield. Elution of  this rather insoluble amino acid from the resin column may well 
have been quite incomplete. On storage several months, yellowing was observed. 
On heating the amino acid decomposed at 225-230 °C. 
When the Strecker synthesis was run on N-methyl, N-butyl or N-phenethyl- 
piperidone, these aminoketones were half-neutralized with HCI before adding the 
KCN, and the reaction run as usual. This neutralization was not considered necessary 
for N-benzylpiperidone because its low apparent pK a (7.2 in water-methanol (1:1, 
v/v)) means that it has little effect on the pH of NH4CN solutions. Water served as 
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the solvent for the Strecker reaction with N-methylpiperidone; for the N-butyl and 
N-phenethyl derivatives, a methanol-water (2: 1, v/v) mixture was used. For the 
phenethyl derivative, the aminonitrile was crystallized, presumably as the dihydro- 
chloride, on adding excess HC1 after the addition reaction. After hydrolyzing this 
intermediate, the amino acid dihydrochloride was titrated in solution to pH 5 or 6 
with the resin Amberlite IR-4B, the monohydrochloride crystallized, and then 
recrystallized as fluffy needles from ten portions of water, yield 40% of that theoreti- 
cally possible from the ketone. On heating sintering led to loss of crystal structure 
without clear melting at 255-260 °C. The yield in the case of the 4-amino-l-methyl- 
piperidine-4-carboxylic acid was 43~/o of the theoretical after two crystallizations from 
absolute alcohol. This compound melted at 243-245 °C without obvious decomposi- 
tion. Sintering was observed to begin at 200 °C during the test. Gratifyingly, this the 
simplest to prepare of the three piperidine amino acids (the 1-dimethyl, the 1-mono- 
methyl, and the unmethylated) proved also the most interesting for transport study. 
(4) 10 mmoles each 4-p-toluenesulfonamidocyclohexanone, NH4CI and KCN 
together were shaken up with 5 ml water to dissolve the principal portion of the 
inorganic salts. Rapid addition of 10 ml of methanol with shaking caused essentially 
complete dissolution of the remaining solids before crystallization began, the tem- 
perature rising to perhaps 40 °C. The solution largely filled with crystals while it was 
held, firmly stoppered, at 40 °C in a hood for 24 h. Further crystallization was en- 
couraged by holding at 5 °C overnight. The mass of the presumed aminonitrile, m.p. 
132-137 °C, suggested a nearly quantitative yield. It was dissolved in hot glacial 
acetic acid in a test tube, 5 ml for each g. An equal volume of 12 M HC1 was then 
added, the tube sealed in a flame, and held overnight at 124 °C in a steam autoclave. 
After evaporating the solvent, the product was separated as usual by frontal elution 
with aqueous NH 3 from IR-120 resin, and crystallized from a near-minimal quantity 
of water by adding two volumes of ethanol. 
(5) Strecker synthesis of ~-(methylamino)isobutyric acid. This amino acid has 
proved so useful as a model substrate for System A that we should record that its 
Strecker synthesis is carried out in the usual way 14 at 94 °C during 10 h in a solution 
containing 3 mmoles of each reactant (acetone, KCN and methylamine hydrochloride) 
per ml of water. The amino acid is crystallized from absolute alcohol, the solubility 
of residual methylamine hydrochloride in alcohol being sufficient to facilitate its 
elimination, with a yield of 18%. A reaction temperature of 100 °C for 20 h led to less 
satisfactory crystallization. The amino acid sintered and sublimed at 226-230 °C 
under the conditions of the melting point determination. 
Bucherer-Libe reaction with 4-p-toluenesulfonamidocyclohexanone 
2.5 g (NH4)2CO 3 was dissolved in 10 ml water. 10 mmoles of the powdered 
ketone was added, and rubbed up with a stirring rod. 10 ml of ethanol were then 
added with mixing and rubbing up of the solid phase. Finally 0.80 g of finely crystalline 
KCN was added all at once, followed by vigorous shaking. This procedure permitted 
essentially quantitative dissolution of the reactants before crystallization of the 
product began. After three days at room temperature the preparation was chilled 
overnight, and the crystallized hydantoin washed with 2:1 aqueous alcohol. The yield 
was 90% of that theoretically possible. 
The hydantoin was hydrolyzed in glacial acetic acid plus HCI by the procedure 
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just described for hydrolyzing the aminonitrile, and the corresponding diamino acid 
separated in 50% yield. Higher yields appeared distinctly possible. Hydrolysis was 
also obtained by heating in 60% H2SO4 terminating at 140 °C when gas evolution 
was complete 15. 
Separation of isomers of 1,4-diaminocyclohexane-l-carboxylic acid 
The crystalline product by the Strecker route typically contained 95-99% of 
a form a migrating more rapidly on eluting with pH 5.28 citrate from the amino acid 
analyzer (Table II), and a few percent of another form emerging some 44 ml later. 
When longer hydrolysis was used, 60% of isomer a and 40% of isomer b was obtained, 
with a lower overall yield. The Bucherer route, followed by HCI hydrolysis, led to 
an approximate inversion of these proportions, typically about 80% of the product 
being in the more slowly migrating form. The isomers could be purified by repeated 
crystallization from aqueous alcohol, b being only about one-third as soluble in 
water as a. 
The unexpectedly low water solubility of the copper salt of isomer b permitted 
a simpler separation. A 0.2-M solution of the amino acid was boiled up with a small 
excess of basic cupric carbonate until the volume was decreased to one-fifth. The 
precipitate, collected after chilling overnight, was washed repeatedly by rubbing up 
thoroughly with water on a sintered-glass filter. Washings after the first two or three 
were discarded. The soluble and the insoluble copper salts were acidified with HCI 
and the resulting solutions freed of Cu z÷ with H2S and taken to near dryness. 
Addition of absolute alcohol led to crystallization of the amino acid dihydrochloride 
of isomer b, the purity of which was confirmed with the amino acid analyzer. Isomer a 
decomposed on heating at 263-268 °C, whereas isomer b decomposed at about 
290 °C, after sintering between 275-285 °C. 
The formation of an unusually insoluble copper salt by isomer b led us to 
suspect that it was the cis diamino acid, both amino groups of which can undoubtedly 
coordinate with Cu 2 +. We have confirmed that supposition by showing that only the a 
isomer, in the form of its methyl ester hydrochloride, cyclizes spontaneously to the 
bicyclic lactam, 4-amino-2-azobicyclo[2.2.2]-octan-3-one, on treatment with an 
excess of freshly precipitated hydrous silver oxide. 
u-C 
This behavior, corresponding to formation of the cyclic lactam by ornithine 16, 
cannot occur when the 4-amino and the 1-carboxyl group are trans to each other. 
Hence the two amino groups must be cis to each other in the b isomer, which shows 
far stronger transport than isomer a by System L of the Ehrlich cell s. The bicyclic 
lactam is, as expected, however, without obvious effect on amino acid transport. A 
close precedent for the formation of the lactam bridge in this case was presented in 
1916 for p-aminohexahydrobenzoic acid, which on dry distillation forms 2-azobicyclo- 
[2.2.2. ]-octan-3-one 17. The present product reverted to the amino acid on hydrolysis 
in boiling HC1. It showed a single pK'a=7.5 on acid-base titration. The infrared 
spectrum was fully consistent with the assigned structure. 
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Conversion of basic amino acids to guanidinoamino acids 
1-Guanyl-4-amino-piperidine-4-carboxylic acid (GPA). 20 mmoles of 4-amino- 
piperidine-4-carboxylic acid (PA) in 100 ml water was boiled up for 10 rain with 1.2 g 
basic cupric carbonate, and the suspension filtered hot, with liberal washing of the 
insoluble residue. A solution of 20 mmoles of O-methylisourea hydrogen sulfate was 
treated under cooling with 10 ml 2.5 M NaOH. The two cooled solutions were then 
mixed. An additional 6 ml of 2.5 M NaOH served to bring the pH to 10.5. After 
several h the volume was reduced to 20 ml. After five days at room temperature, 
30 ml of 2 M HC1 were added, Cu 2+ was removed with H2S and the CuS washed 
thoroughly with hot water. After evaporating the filtrate to 10 ml, a major crop of the 
slightly soluble sulfate was collected after chilling overnight, to give 60-68% of the 
theoretically possible yield. This amino acid decomposed on heating at 279-283 °C. 
Even when the preparation of the precursor amino acid used had contained 
about 5% of an unidentified contaminant, the sulfate of the guanyl derivative was 
chromatographically pure, and showed an equivalent weight of 281 (calculated for 
C T H 1 6 N 4 O r S  , 284) on titration with 0.25 M Ba(OH)2 solution. No Ba 2+ remained 
in the solution when the titration was terminated at pH 10. After removing BaSO4, 
the filtrate was concentrated until the crystals forming could barely be redissolved 
at the boiling temperature. The crystals were collected after chilling overnight. The 
yield from this step was essentially quantitative. 
The same procedure was used for guanylating the a isomer of 1,4-diamino- 
cyclohexane carboxylic acid. The product crystallized as the isoionic amino acid in 
60% yield, after removing anions by titration to pH 10 with Dowex 1-hydroxide resin. 
Recrystallization from water was needed to eliminate a trace of the precursor diamino 
acid. The crystals decomposed gradually on heating to 288-298 °C. 
1-Guanyl-4-piperidineglycine (GPG). Guanylation was carried out on the copper 
salt of 5-piperidineglycine in the same way except that 0.2 M Ba(OH)2 was substituted 
for NaOH. After a few h the suspension was taken to about one-third of its volume by 
vacuum distillation at less than 30 °C. After standing five days, the BaSO4 was 
filtered from the solution, and one equivalent of HCI added per mole of amino acid 
used. Copper was removed with H2S, and the filtrate taken to a thick sirup in vacuum. 
After taking up the residue in water, it was titrated batchwise from pH 1.5 to 4.5 with 
Amberlite IR-4B resin in the free amine form. The filtrate plus abundant washings 
from this resin treatment was again taken to a sirup, and crystallization initiated by 
scratching the interior of the flask with a glass rod. A crystalline form presumed to be 
the monohydrochloride separated as needles, and was recrystallized from water to 
give a 55% yield. Titration of a solution of this salt to pH 11 caused crystallization 
of the isoionic form of the amino acid. On heating the amino acid decomposed at 
about 305-310 °C. 
4-Amino-l-carbamoylpiperidine-4-carboxylic acid (CPA). In a 0.2-0.25 M solu- 
tion of 1-20 mmoles of PA as its copper salt, was dissolved in an open beaker 1.1 molar 
equivalents of potassium cyanate Is. By passing 5°/0 CO2 through the solution, either 
very slowly or else intermittently during three days the pH was kept in the approximate 
range 9-10. Two treatments with CO2 per day sutficed. A copper salt began to crys- 
tallize after about two days in early runs, but in some later runs crystallization began 
within an hour. After four or five days or more, the gleaming blue crystals were 
filtered off and washed with water. The product was dissolved to roughly 0.05 M in 
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water containing at least an equivalent of HC1. CuS was precipitated as usual at 
room temperature and washed well with hot water. After removal of  H2S the solution 
was concentrated in vacuo to about 0.5 M. Crystals formed during the evaporation. 
After chilling the suspension overnight, the well-washed crystals represented a 
50-60% yield. On heating, the amino acid decomposed at 278-281 °C. The above 
preparation of  CPA was quite as convenient when we used 1 mmole of the [14C]- 
carboxyl precursor amino acid. 
Radioactive labeling of  amino acids 
Radioactive preparations of several of the other substances were made using 
K14CN in either the Strecker or the Bucherer-Libe reaction, without significant 
change except for the obvious scaling downward of quantities. In the cases of 4- 
amino-l-methylpiperidinecarboxylic acid (MPA), and 4-piperidineglycine (PG), the 
final products were purified by chromatography on Whatman No. 3 paper, extracting 
only the band of paper showing the characteristic maximum of  radioactivity on strip 
counting. A 100-ml sample of PG was tritiated for us by the Wilzbach procedure by 
the New England Nuclear Corporation. The product was guanylated as above and 
crystallized in isoionic form. 
Characterization. Melting behavior as described above was examined with the 
use of the Fischer-Johns melting point block. Table I records analytical values for 
the products. The amino acids were titrated at 25 °C in aqueous solution, 0.05-0.1 M, 
NaCI added to I=0.15.  The following values were observed for PK'2: PA, 7.5; its 
derivatives: 1-methyl (MPA), 7.2; 1-dimethyl (M2PA), 7.0; 1-butyl, 7.2; 1-benzyl, 
6.7; 1-phenethyl, 7.1 ; and 1-guanyl (GPA), 8.0; also cis-l,4-diaminocyclohexane-1- 
carboxylic acid, 8.4. pK'a values were approximately as follows, MPA, 9.7; the 
corresponding 1-benzyl amino acid, 9.3; the 1-phenethyl amino acid, 9.4. The change 
in the ultraviolet spectrum of the benzylpiperidine amino acid on acid-base titration 
TABLE I 
ANALYTICAL VALUES FOR PREPARATIONS 
Calculated Found 
C H N C H N 
4-Aminopiperidine-4-carboxylic acid, 
CeI-I1202N2 (PA) 50.0 
4-Amino-l-methylpiperidine-4-carboxylic 
acid, C7I-I1402Nz (MPA) 53.1 
4-Amino-l-guanylpiperidine-4-carboxylic 
acid, C7H1402N4 (GPA) 45.2 
4-Amino-l-carbamoylpiperidine-4- 
carboxylic acid, C~HlsNaOa (CPA) 44.9 
1 -Guanylpiperidineglycine, CaHleO~N4 
(GPG) 48.0 
1,4-trans-Diaminocyclohexane-4-carboxylic 
acid monohydrate, CTHxrNaO3 53.1 
Inner lactam of same, CTHlzON8 60.0 
8.4 19.4 49.2 8.2 19.1 
8.9 17.7 53.0 9.0 17.5 
7.5 30.1 45.2 7.4 30.2 
7.0 22.5 44.7 6.9 22.3 
8.1 28.0 48.0 8.3 27.6 
8.9 17.7 53.0 9.0 17.5 
8.1 20.0 60.2 8.1 19.7 
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is recorded elsewhere s. Table II  records the volumes at which the amino acids emerge 
f rom the ion-exchange resin columns of  the amino acid analyzer (Phoenix). The same 
table also records the chromogenici ty o f  the amino acids with ninhydrin for  this 
analyzer, and the retardation factors o f  the piperidine amino acids on paper 
chromatography.  
TABLE II 
VOLUME OF ELUTION AND CHROMOGENICITY OF AMINO ACIDS ON THE AMINO 
ACID ANALYZER 
Re values on paper chromatograms. Columns 2A (10 cm) and 2 (20 cm) were filled with resins 
designated XX8-10-I and XXS-20-I, and eluted with 0.35 M sodium citrate buffer, pI-I 5.28. 
Column 1 (60 cm) was filled with the resin designated XX8-60-I, and was eluted with 0.2 M 
sodium citrate buffer at pH 3.25 for the first 93 ml, and then at pH 4.25, all at 50 °C and at a 
flow rate of 80 ml/h. The column used, when not 2A, is indicated in parentheses in the central 
column of the table. The color constants were calculated as the height times the width of the 
peak for 570 nm wavelength, per mieromole of amino acid, the color constant for lysine being 
17.7. Paper chromatograms were developed with a solvent composed of 40 vol. ethanol, 2.5 vol. 
concentrated aqueous ammonia and 7.5 vol. water. 
Amino acid Migration on chromatography 
1on-exchange column 
Column Other  Color 
2A columns constant 
RF on paper 
chromatograms 
4-Aminopiperidine-4-carboxylic acid (PA) 25.2 2.38 0.39 
1-Methyl derivative (MPA) 26 2.32 0.55 
1-Dimethyl derivative (M2PA) 28 203 (1A) 1.49 0.34 
1-Carbamyl derivative (CPA) 77 (1)* 2.10 0.29 
l-Guanyl derivative (GPA) 36 116 (2) 2.85** 0.32 
1,4-Diaminoeyclohexane- 1-carboxylic acid 
cis 23.9 2.30 
trans 19.9 2.30 
* At 30 °C, elution was at 93 ml. 
** The absorbance at 570 nm was 6.7 times that at 440. 
Test o f  behavior o f  the synthetic amino acids and homoarginine in the intact rat 
L-Homoarginine hydrochloride,  containing 0,05% lysine, and (EL q- meso)<t,e- 
diaminopimelic acid were obtained f rom Calbiochem, and 2-amino-3-ureido-pro- 
pionic acid f rom Cycle Chemical Company.  Otherwise we used the synthetic amino 
acids described above. 
Labeled amino acids were administered at doses of  1-16/~moles (1-10 #Ci) to 
fasted 50-g male rats. The animal was subsequently kept in an all-glass apparatus  
under  an air stream. The air drawn through the container was passed through two 
successive towers containing glass beads covered with a methanolic Hyamine  
hydroxide solution for  collection o f  expired CO2. 
Male albino rats o f  100-300 g were kept without  food for 16-18 h and about  
10 ml o f  an isoosmolar  or  a slightly hyperosmolar  solution o f  the synthetic amino 
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acids then injected intraperitoneally at doses of 5-10 mmoles/kg body weight. Urine 
collections were arranged as described previously 19. Control animals received an 
equal volume of 0.15 M NaC1 solution by the same route. 
Endogenous amino acids present in the urine (and in some cases in the plasma) 
were measured by ion-exchange chromatography using a Phoenix amino acid 
analyzer. Details appear in the legends to the tables. Radioactive tracers were measured 
by liquid-scintillation counting in ethanol-toluene, using a standard phosphor and a 
Packard scintillation spectrometer. 
Tests for increases in circulating insulin and glucagon in rats receiving the cationic 
amino acids 
8 mmoles of the amino acid (10 mmoles of GPG) per kg body weight were 
administered as just described. The rats weighed 50-140 g for the insulin studies, 
100-200 g for the glucagon studies. Control animals again received 0.15 M NaCI 
solutions. 27 rain later, blood samples were taken from the superior vena cava with 
the animal under ether anesthesia. Serum samples were then separated and subjected 
to a double-antibody radio-immunoassay 2° as applied elsewhere 21 for one or the 
other hormone. Because the immunizing hormones were not homologous, the levels 
observed in the rat are considered relative rather than absolute. These assays were 
made for us through the kindness of Dr Stefan Fajans and Dr Sumer Pek of the 
Endocrinology and Metabolism Unit, Department of Medicine. The results with rats 
stimulated us to synthesize GPA in the quantities required for studies in the dog, for 
the collaborative test to be described shortly. 
RESULTS 
Apparent metabolic release of 14C02 from the carboxyl-labeled amino acids 
After administering 1-16/tmoles (1-10 #Ci) intraperitoneally to 50-g rats, the 
expired 14CO2 collected in Hyamine hydroxide during 24 h was 0.07-0.12% of the 
administered dose for PA, MPA, GPA and CPA. A slightly higher figure of 0.35% 
observed for M2PA seems likely from the moderately greater difficulties of purification 
to reflect a slightly lower purity of the preparation, rather than a higher vulnerability 
to metabolic attack, whereas the release of 2.4% from PG is likely to represent 
significant if slow metabolic attack. The presence of an ~-H in it is of course a source 
of vulnerability. Note that attack by intestinal microorganisms, as well as imperfect 
purity, is a plausible source of the very slowly released 14CO2 from the preparations 
bearing the amino and carboxyl group on the piperidine ring. Accordingly we 
question whether any attack of most of these compounds occurs in the organism of 
the rat, per se. 
No radioactivity was found on paper chromatograms of the urine samples 
collected during these tests except at the Rr for the administered amino acid. An 
anthracene scintillation flow-cell showed that 1.1% of the urinary 14C administered 
to the rat as [1-14C]GPA emerged from the column of the amino acid analyzer just 
before glutamic acid, rather than at the position characteristic of this analog. 
Renal excretion of 14C-labeled amino acids administered parenterally to the rat 
Fig. 2 compares the rates of the early urinary losses of the model amino acids 
tested at low dosages in this study, before the subsequent phase of an exponential 
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rate of  loss was established. From 43-63% of the test dose was lost during the first 6 h. 
During this time the amino acid largely passes out of  the peritoneal space, a competi- 
tion being set up between uptake by various tissues and loss into the urine. Because 
several rate constants must contribute, the shapes of  the curves during this interval 
are not easily analyzed. We may note, as a gross effect, that adding the 1-methyl 
group to the piperidine amino acid about halves the rate of  loss during the first 2 h, 
the 1-guanyl group is somewhat less effective in this respect. 
We may note for contrast with the new amino acids that during the same 6-h 
period the urinary losses of  ~t,~-dicyclopropylglycine and ~,~-diethylglycine, two 
amino acids designed for minimal transport, were 90% or more 19. Nevertheless 
some accumulation of the latter by liver 19 and some uptake of it by brain slices a 
have been observed. An opposite contrast is presented by the minimal loss of  a much 
more effective renal transport model, 0~(methylamino)-isobutyric acid 19, as shown by 
dashed curve at the bot tom of Fig. 2. 
A somewhat clearer comparison of  renal behavior with respect to these model 
amino acids is provided by an exponential phase established after about 24 h (illustrated 
for GPA and PA in Fig. 3) and continuing as long as excretion remained measurable. 
This phase concerns a retained 20-50% of the administered amino acid dose. The 
linearity seen in Fig. 3 would be expected if a constant proportion of the amino acid 
retained in the body is present in the plasma and if a constant proportion of  that 
contained in the filtered plasma is not resorbed. The half-times thus indicated for 
renal loss are as follows: GPA, 46 h; M2PA, 31 h; PG, 19 h; CPA, 17 h; PA, 10 h; 
MPA, 7 h. I f  we recall that l-aminocyclopentane-carboxylic acid shows a biological 
half-life of  22 days for renal excretion by the mouse (3.5 days in man) we may conclude 
that  acceptance of  these piperidine amino acids by the renal transport mechanisms is 
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Fig. 2. Cumulative urinary excretion of z4C-labeled amino acid analogs during the first day after 
injection. Dosages were 1/amole in 0.5 rnl 0.15 M NaC1 into a 45-50-g rat, except that 11/zmoles 
of CPA and 16 #moles of GPA were injected as indicated in parentheses. (The results are probably 
not dose-dependent at these low dosages.) The curves marked DCG (~t,~-dicyclopropylglycine), 
DEG (~,~-diethylglycine) and MeAIB (0¢-(methylamino)isobutyric acid) are taken from ref. 19. 
Fig. 3. Decline in rate of urinary excretion of 4-amino-l-guanylpiperidine-4-[z4C ]carboxylic acid 
(upper two lines) and 4-aminopiperidine-4-[z4C ]carboxylie acid (lower line) during several days 
after intraperitoneal injection into the rat. 40-50-g animals received 3-16 pmoles (I-5 pCi) of the 
test amino acid in 0.5 ml 0.15 M NaC1. The slopes of the principal linear plots correspond, in the 
order shown, to half-times of retention in the animal of 39, 44 and 9.4 h. 
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only fair, even though most of  the filtered amino acid must be resorbed. The lower 
resorption rates did not prevent our establishing sufficient concentrations of  them to 
largely saturate the relevant transport agencies, as described in the next section. 
Effects o f  test compounds on renal excretion of  endogenous~Jnino acids in the rat 
Table I I I  summarizes the principal effects of  the model amino acids under 
study, after intraperitoneal injection of large doses into the rat. The numbers in the 
body of the table indicate by what factor the urinary excretion of the amino acid 
named at the head of the column was typically increased. For example, the injection 
of homoarginine, 5 mmoles/kg of body weight, led to an increase of  citrulline excretion 
by 104-fold, of  cystine excretion by 44-fold, of  lysine excretion by 168-fold, and so on. 
No significant change was seen in the excretion of neutral amino acids except as 
mentioned below. Although lysine is a likely intermediate in the slow metabolism 
of homoarginine, homoarginine administration led to no perceptible increase in the 
plasma lysine. Homoarginine is known to be much more resistant to arginase action 
and other metabolic attack than arginine 22'23. 
Although the guanylpiperidine amino acid shows somewhat lower transport  
affinities than arginine or homoarginine in all systems tested s, and indeed very little 
in Escherichia coli and Salmonella typhimurium, the injection of doses of  5 mmoles/kg 
body weight always strongly intensified the urinary excretion of the same five en- 
dogenous amino acids. The abbreviation "obsd"  in Table I I I  indicates that the 
TABLE III 
EFFECTS OF THE INTRAPERITONEAL INJECTION OF AMINO ACID ANALOGS 
INTO THE RAT ON THE URINARY EXCRETION OF FIVE NATURAL AMINO ACIDS 
Administered Number of times by which urinary excretion was increased for: 
Citrulline Cystine Lysine Orni th ine  Arginine 
Arginine analogs 
Homoarginine 104 44 168 36 43 
GPA 12 23 217 43 25 
GPG* 17 3 7 2 obsd 
Citrulline analog 
CPA obsd 13 114 17 10 
Supposed lysine analogs 
PA 4 0 0 0 0 
PG (8 mmoles/kg) 29 0 obsd obsd 0 
(Lysine) 24 
Neutral amino acids 
~-Aminoisobutyric acid* * 0 5 2 0 0 
* Note dose of L form only 2.5 mmoles/kg. Tests at 8 mmoles showed citrulline still most 
affected. Increases in the other basic amino acids and oystir~ ~ associated with rises in the 
neutral amino acids. 
** Doubled doses gave large increases in cystine, lysine and excretion of many neutral amino 
acids 19, but not of citrulline. 
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chromatographic peak for the indicated amino acid was completely obscured by the 
test amino acid. For  example, the presence of the citrulline analog unfortunately 
obscured the analytical result for citrulline itself, although its administration stimu- 
lated the excretion of all four of  the other endogenous amino acids tabulated. 
G P G  at the test dose of 5 mmoles/kg (undoubtedly including only 2.5 mmoles 
of  the L isomer) had an effect largely limited to citrulline excretion; but at a dose of 
8 mmoles/kg the losses of  all of  the same five amino acids were affected. The supposed 
lysine analogs, PA and PG, had effects largely limited to citrulline excretion, although 
smaller effects were seen on the losses of  some other neutral amino acids, in particular 
on the sum of asparagine and glutamine (not shown in Table III). For  example 
5 mmoles/kg of PA increased this sum to 3.4-fold, and 8 mmoles increased it to 
9.4.-fold, in each case more than for any other neutral amino acid. The same dose of  
MPA doubled glutamine plus asparagine excretion. The effects on renal amino acid 
excretion are discussed in a later section. 
Stimulation of  increases in the circulating levels of  immune-reactive insulin and glucagon 
Table IV summarizes our observations of  the changes on the apparent levels of  
the circulating hormones in the rat 27 min after administration of the amino acids. 
This time interval had been selected on the basis of  only a few tests of  shorter and 
longer times. I f  the effects in the rat had been as transient as those seen subsequently 
in the dog at a dose of about 1 mmole of GPA per kg body weight, no significant 
effects would have been seen at the time interval selected for the rat. 
A general screening of GPA for significant pharmacological effects, other than 
that reported here, has been carried out with largely negative results under the 
direction of Dr  Robert  A. Maxwell of  the Burroughs-Wellcome Research Labora-  
tories, Research Triangle Park, N. C. These results support the conclusion that the 
actions are direct ones on the endocrine tissue, and not a result of other disturbances. 
TABLE IV 
APPARENT LEVELS OF CIRCULATING IMMUNORESPONSIVE INSULIN AND 
GLUCAGON IN TIlE RAT 27 min AFTER ADMINISTRATION OF MODEL AMINO 
ACIDS 
Preliminary reports of these findings were made earlier ~, s. The control population received an 
equal volume of NaC1, the observations being interspersed among the experiments. 
Administered Insulin Glucagon 
(Itunits/rnl _+ S.D.) (ng/ml _+ S.D.) 
0.15 M NaCI 4.5_+1.7 (19) 0.39_+0.17 (9) 
GPG 10.7_+ 2.1 (7) 1.05 +_.0.15 (6) 
GPA 9.4_+ 2.7 (13)* 0.90 _+ 0.32 (8) 
Bis-~t,~t-hydroxymethylglycine ~4 16.0_+0.7 (4) 0.51 _+0.06 (2) 
Ilomoarginine 17.8 _+ 4.6 (3)* * 1.17 _+ 0.70 (3) 
Arginine 14.5 _+ 3.4 (6) 0.84_+ 0.28 (3) 
at-N-Methylarginine 4.6 _+ 0.46 (2) 0.26 _+ 0.03 (2) 
CPA 0.42 _+ 0.20 (2) 
* Effect confirmed by similar increases in 8 rats, 100-200 g. 
** Effect confirmed by slightly smaller increases in 7 rats of 100-200 g. 
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The same conclusion is supported by the subsequent finding that GPA stimulates 
the release of insulin from pancreatic islets isolated from an obese, diabetic strain 
of mice 2s. 
Discussion of  the effects of  the administered amina acid on" urinary excretion of  other 
amino acids 
According to the results of Table III, citrulline now joins cystine as a neutral 
amino acid associated with the renal tubular resorption of the cationic amino acids. 
The possibility that citrulline excretion occurs in cystinuria received consideration 
some years ago. Traces of this amino acid were observed by Dent and Rose 26 in the 
urine of human cystinuric patients, but they attributed this finding to bacterial attack 
on arginine after collection of the urine. Treacher 27 found citrulline in the urine of 
cystinuric dogs, but because he failed to observe citrulline in the plasma, he proposed 
a renal origin. Others have, however, not encountered difficulty in measuring plasma 
citrulline in the dog. Asatoor et al. 28 found citrulline in the uncontaminated urine of 
cystinuric patients who showed no evidence of kidney infection, especially after 
arginine administration. They concluded, however, that the citrulline was formed 
from unabsorbed arginine by bacteria in the alimentary tract, and that the citrullinuria 
was of an "overflow" type. Accordingly, we find no well supported prior evidence 
that the renal resorption of citrulline may be subnormal in association with the 
otherwise well-known aminoaciduria of the cystinuric patient. The present observa- 
tions appear to be the first of mutual inhibition of renal resorption between citrulline 
and the amino acids principally lost in cystinuria. 
Administration of the arginine analogs raised the excretory rate for the 
endogenous basic amino acids, for cystine and for citrulline. Conversely, administra- 
tion of the non-metabolizable citrulline analog stimulated the excretion of the basic 
amino acids and cystine, citrulline itself being obscured from analysis in this case. 
Furthermore lysine administration also stimulated a citrullinuria. The supposed 
lysine analogs PA and PG had effects largely limited to citrulline excretion, the basic 
amino acids being little affected. 
Experiments in the Ehrlich cell have indicated that the membrane receptor sites 
tend to "see" these lysine analogs with the piperidine N unprotonated, even though 
the protonated species is abundant in free solution. In the Ehrlich cell their effects 
on cationic amino acid transport are weak, unless the piperidine N is rendered un- 
ambiguously cationic by dimethylation or by guanylation a, much as observed here 
for renal transport. The circumstances that lysine clearance and lysine excretion 29 are 
increased in Hartnup's syndrome suggests either that a substantial proportion of the 
renal resorption of lysine also occurs by a neutral amino acid system, or that one or 
more of the neutral amino acids accumulating in the tubular urine in this disorder 
interferes substantially with lysine resorption. 
These results show that the resorption of citrulline can be inhibited indepen- 
dently and hence has a point of vulnerability not shared with basic amino acids or 
with cystine. Furthermore, at low doses GPG increased principally citrulline excretion. 
These results are not compatible with a migration by the same transport system as 
citrulline and the basic amino acids, even though at, sufficient levels an interaction for 
transport does occur between citrulline and its analogs, on the one hand, and arginine 
and its analogs, on the other. 
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Furthermore cystine resorption has a point of vulnerability not shared with 
citrulline. Although ~-aminoisobutyric acid at a dose of 5 mmoles/kg body weight 
does not provoke increased loss of  the endogenous amino acids under discussion, at 
10 mmoles/kg a general aminoaciduria is provoked including cystine and the cationic 
amino acids, but not citrulline, a point we checked repeatedly. 
Citrullino and ,~ Amino acid-site =_ Tubular resorption 
analog (but no1 complex No, I 
most neutral • • s" I*"  
amino acids ) • i 
s • s "  • 
s %. 
Cationic =. Amino acid-site = Tubular resorption 
amino acids ~,.,, complex No. 2 
Cystine =. Amino acid-site = Tubular resorption 
complex No. 3 
Fig. 4. Interpretation of the interaction among the cationic amino acids, citrulline and cystine 
for renal tubular resorption. Dashed arrows indicate inhibition without transport. It has not been 
proved that the transport site marked No. 2 is different from the one marked No. 3, although 
Nos 1 and 3 must be different. 
Fig. 4 offers a model to present these relations. It becomes necessary to conclude 
that citrulline and the basic amino acids plus cystine are not resorbed by the same 
transport system. Hence we must picture a mutual inhibitory interaction between 
citrulline and the cationic amino acids not based on a shared route. That is, the site 
that recognizes and transports citrulline cannot be the same one that recognizes and 
transports the cationic amino acids. The dotted lines of  Fig. 4 therefore indicate 
inhibition of  a transport system without significant accompanying transport, an 
action that occurs here in both directions. Substantial precedent for inhibition of  
transport without shared transport has been obtained between amino acids of like 
charge as well as with amino acids of unlike charge 3°-32. Such effects may well tend 
to be maximized in the renal tubular system, because of  the tendency of a poorly 
resorbed solute to reach very high levels in the tubular urine. 
The temptation arises at this point to lump cystine and probably glutamine 
together with citrulline into a single transport system requiring a nitrogen-beating 
sidechain without net charge. But the transports of citrulline and cystine can be 
independently inhibited, so evidently they also cannot be transported by the same 
agency. By analogy with the case for citrulline, the most conservative position 
remaining is to propose that cystine migrates by a third transport system which can be 
inhibited by either citrulline analogs or arginine analogs. We have not, however, so 
far been able to inhibit cystine resorption independently of cationic amino acid 
resorption. Therefore we cannot yet refute unequivocally Dent's placement of cystine 
in the same family with the basic amino acids for tubular resorption, based on the 
pattern of amino acids lost together in cystinuria, although for the present Dent's 
hypothesis becomes less likely. Thier and Segel a3 have reviewed other evidence not 
obviously consistent with the Dent hypothesis. 
In Fig. 5 we see for comparison structures for two of  the basic amino acids, 
also for cystine and for citrulline. The trouble with placing cystine in the cationic 
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REEXAMINATION OF AN EXTENDED DENT ANALOGY 
co~ ..3* co; N.; CO; N.~ CO; .N; 
\CH '  \CH / "CH / CH 
I I I t 
c.,  c . ,  .c., c . ,  
CH2 CH2 S CH 2 
I I I / 
CHt CH2 S CH2 
I 
C~2 NH, CH, NH 
N NH~ H2N- C=NH~" CH O=C-NH~, 
"02C / \ NH~ 
Lysine Arginine Cystine Citrulline 
Discrepancies 
I.Dislal corboxyl group of cystine needs neutralization 
2.Amido group of citrulline can scarcely be protonated 
Fig. 5. Comparison of structural formulas of some of the amino acids under discussion. See text 
for discussion. 
amino acid transport family is what to do with the charged distal carboxylate group, 
a difficulty often rendered unobvious by the poor practice of drawing the structural 
formulas of amino acid in their non-zwitterionic forms. We can detect no transport 
system in isolated animal cells that will accept such a two-headed amino acid. The 
environment into which this carboxyl group enters would need to be very apolar 
indeed to permit it to be stabilized in the protonated form, unless a chemical group 
at the receptor site participates in stabilizing it in that form. The analogous effects 
of the citrulline analog on basic amino acid transport might permit us to picture H + 
as being transferred from the distal amino to the distal carboxylate group on com- 
bination of cystine with the receptor site. The analogy of the cystine structure with 
that of the basic amino acids would then be substantially weakened, and cystine 
would be seen rather plausibly instead as an analog of citrulline and glutamine. 
Apparently any such tendency is not so strong, however, as to permit cystine and 
citrulline to share mainly the same transport process. 
It is even less likely that the ureido structure of citrulline could come to be 
protonated in combining with the receptor site to make it an analog of lysine and 
arginine. The more plausible explanation is that citrulline and glutamine, and perhaps 
also asparagine, constitute a newly identified family, transported by a heretofore 
undescribed system, and that their interaction with cationic amino acids for renal 
tubular transport, as illustrated in Table IV, is based on a fit with the receptor site 
sufficient to produce inhibition of transport although the complexed structure is not 
such as to permit transport to follow binding. The same relation is suggested for 
cystine with, however, insufficiently clear support for the present for the separateness 
of the transport of this amino acid. 
We need amino acid structures closely analogous to cystine and glutamine to 
complete the discrimination of these systems. These compounds should lack the 
notable biological instability of the two natural amino acids, especially the suscep- 
tibility of'cystine to reductive cleavage. For example, in E. coli ~,e-diaminopimelic 
acid is transported by a system serving for cystine s4. It is significant that diamino- 
pimelic acid administration provoked increased lysine excretion in the rat (Table V), 
although the circumstance that arginine and ornithine excretion did not rise leaves 
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TABLE V 
LYSINURIA IN THE RAT AFTER ADMINISTRATION OF (L+meso)-~,e-DIAMINO- 
PIMELIC ACID 
(10 mmoles/kg body weight). Illustrative results. The numbers show the factor by which the rate 
of urinary excretion of histidine and lysine was increased. Urinary arginine and ornithine were 
not increased; other urinary amino acids obscured. Plasma lysine was not increased. 
Time after Number of  times by which 
administration urinary excretion was increased 
(h) 
Histidine L ysine 
2 5.9 7.4 
5 2.5 7.4 
5 5.1 19.9 
equivocal the interpretation of that result. Since plasma lysine was not increased, 
the lysinuria was not prerenal. Our efforts so far indicate some difficulty in designing 
stable structural analogs of cystine that show cystine-like behavior in the renal tubule. 
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